# A Clinical Study in Health Subjects to Evaluate 9MW1411 Injection

> **NCT04784312** · PHASE1 · COMPLETED · sponsor: **Mabwell (Shanghai) Bioscience Co., Ltd.** · enrollment: 42 (actual)

## Conditions studied

- Staphylococcus Aureus Infection

## Interventions

- **COMBINATION_PRODUCT:** 9MW1411 injection
- **COMBINATION_PRODUCT:** 9MW1411 injection placebo

## Key facts

- **NCT ID:** NCT04784312
- **Lead sponsor:** Mabwell (Shanghai) Bioscience Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-16
- **Primary completion:** 2021-08-17
- **Final completion:** 2021-08-17
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2022-06-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04784312

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04784312, "A Clinical Study in Health Subjects to Evaluate 9MW1411 Injection". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04784312. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*